We are pleased to announce the commercialization of “N-NOSE plus Pancreas”, the world’s first cancer type specific test, the next generation of the N-NOSE nematode cancer test.
“N-NOSE plus Pancreas”, the world’s first test to detect early-stage pancreatic cancer, is now available for practical use.
→PRESS RELEASE
Japan’s Ministry of Health, Labour and Welfare (MHLW) recently updated its Guidelines for New Business Activities in the Healthy Life Expectancy . . .
2025.04.08The original research article demonstrating the efficacy of N-NOSE in detecting blood cancers (also known as hematological malignancies) has bee . . .
2025.03.31HIROTSU Bioscience Corporation (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu) announces that it has implemented a Third-Party . . .
2025.03.31